3 Amendments of Françoise GROSSETÊTE related to 2013/2022(INI)
Amendment 89 #
Motion for a resolution
Recital K a (new)
Recital K a (new)
Ka. whereas, in view of the lack of development of new antibacterial medicines, the Commission and the Member States should work together to support the development and availability of such products, making use of the European Centre for Disease Prevention and Control (ECDC) and the expertise of the European Medicines Agency (EMA);
Amendment 235 #
Motion for a resolution
Paragraph 35 b (new)
Paragraph 35 b (new)
35b. Calls on the European Centre for Disease Prevention and Control (ECDC) to draw up, in cooperation with the European Medicines Agency (EMA), a list of pathogens that can cause serious or potentially fatal antibiotic-resistant infections and pose a serious health risk; calls for that list to be updated on a regular basis with information supplied by the ECDC’s European Surveillance of Antimicrobial Consumption Network (ESAC-Net) and European Antimicrobial Resistance Surveillance Network (EARS- Net);
Amendment 236 #
Motion for a resolution
Paragraph 35 a (new)
Paragraph 35 a (new)
35a. Calls on the Commission and the Member States to cooperate in introducing incentives for the development of new antibacterial medicines; considers that these incentives should be introduced as part of an appropriate EU legislative framework, with a view to fostering cooperation between the public and private sectors in order to revitalise antimicrobials-related research and development;